Articles T67 Số CDD10 - HN Bệnh viện Nhi Đồng 2 - HN Trường Đại học Nguyễn Tất Thành

SEGMENTECTOMY IN NON SMALL CELL LUNG CANCER MANAGEMENT: INDICATION AND EXPERIENCE IN CHO RAY HOSPITAL

Nguyen Hoang Binh1,2, Nguyen Le Phuc1,2, Truong Cao Nguyen1,2, Pham Thanh Viet1,2
1 Cho Ray Hospital
2 Bệnh viện Chợ Rẫy
DOI: 10.52163/yhc.v67icd10.6191
0 Views
0 Downloads
Keywords
Segmentectomy
Abstract

Introduction: With the development of diagnosis techniques in lung cancer and the screening programs of lung cancer, many small and early lesions were detected on CT scans. Segmentectomy is the surgical procedure that can preserve lung function and radical surgery for early stage lung cancer. We review the indications of segmentectomy in lung cancer management and the initial result of segmentectomy at Cho Ray Hospital.

Method: Update literature - based review of indication for segmentectomy and a retrospective description of five patients performed for segmentectomy at Cho Ray Hospital.

Result: 5 early stage lung cancer patients are performed for segmentectomy: 4 patients were S6 segmentectomy, 1 patient was done lingulectomy.

Conclusion: Segmentectomy is indicated in non-small cell Lung cancer patients with peripheral nodules less than 2cm, no involved lymph nodes. Segmentectomy is safe and effective for treating lung cancer. Most patients performed segmentectomy at Cho Ray Hospital are S6 segmentectomy.

References
[1]
Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995;60(3):615-22; discussion 622-3. Google Scholar
[2]
Okada M, Yoshikawa K, Hatta T, et al. Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller? Ann Thorac Surg. 2001;71(3):956-60; discussion 961. Google Scholar
[3]
Suzuki K, Saji H, Aokage K, et al. Comparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial. J Thorac Cardiovasc Surg. 2019;158(3):895-907. Google Scholar
[4]
Altorki NK, Wang X, Wigle D, et al. Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503). Lancet Respir Med. 2018;6(12):915-924. Google Scholar
[5]
Altorki N, Wang X, Kozono D, et al. Lobar or Sublobar Resection for Peripheral Stage IA Non-Small- Cell Lung Cancer. N Engl J Med. 2023;388(6):489-498. [PMID:36780674] Google Scholar
[6]
Onaitis MW, Furnary AP, Kosinski AS, et al. Equivalent Survival Between Lobectomy and Segmentectomy for Clinical Stage IA Lung Cancer. Ann Thorac Surg. 2020;110(6):1882-1891. Google Scholar
[7]
Saji H, Okada M, Tsuboi M, et al. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet. 2022;399:1607-1617. Google Scholar